Learn More
R&D Systems™ Recombinant Human TGF-beta 1 Protein CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 240-B-500/CF
Description
Measured by its ability to inhibit the IL-4-dependent proliferation of HT-2 mouse T cells. Tsang, M. et al. (1995) Cytokine 7:389. The ED50 for this effect is 0.04-0.2 ng/mL. The specific activity of Recombinant Human TGF-beta 1 is approximately 2.5 x 104 U/μg, which is calibrated against human TGF-beta 1 Standard (NIBSC code: 89/514). Specific activity is for reference purposes only and is not routinely tested.Specifications
| P01137 | |
| Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA. | |
| 12.8kDa (monomer) | |
| Chinese Hamster Ovary cell line,CHO-derived human TGF-beta 1 protein Ala279-Ser390 | |
| <0.10EU per 1μg of the protein by the LAL method. | |
| TGFB1 | |
| Unconjugated |
| Bioactivity | |
| 7040 | |
| 500μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| CEDLAP, DPD1, latency-associated peptide, TGF beta1, TGFB, TGFB1, TGFbeta, TGFbeta 1, TGF-beta 1 protein, TGF-beta-1, transforming growth factor beta-1, transforming growth factor, beta 1 | |
| Recombinant Protein | |
| Reconstitute 2μg vials at 20μg/mL in sterile 4 mM HCl containing at least 0.1% human or bovine serum albumin. Reconstitute 10μg or larger vials at 100μg/mL in sterile 4 mM HCl. |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.